ASK REDCHAT ANYTHING ABOUT BIO-PATH HOLDINGS INC.
Bio-Path Holdings Inc. (OTCQB: BPTH)
Listen to this Section
$0.04
+0.0050
(
+16.67% )
67.3K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Prexigebersen (BP1001)DetailsAcute myeloid leukemia, Cancer |
Phase 2 |
| BP1002DetailsAcute myeloid leukemia, Blood cancer, Cancer |
Phase 1 |
| BP1002DetailsLymphoma, Chronic lymphocytic leukemia, Blood cancer, Cancer |
Phase 1 |
| BP1001-ADetailsSolid tumor/s, Cancer |
Phase 1 |
Market Data
|
| Open |
$0.04 |
| Previous Close |
$0.06 |
| Volume |
67.3K |
| Market Cap |
$1.76M |
| Day Range |
$0.03 - $0.04 |
| 52 Week Range |
$0.05 - $0.23 |
| Shares Outstanding |
50.30M |
| Change % |
+16.67% |
| Net Change |
▲ 0.0050 |
| Insider Ownership |
0.00% |
| Exchange |
OTCQB |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-34,537.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-08-01 |
Sale |
-25000.00 |
Nielsen Peter Henry |
| 2024-08-01 |
Sale |
-3537.00 |
MORRIS DOUGLAS P |
| 2024-08-01 |
Sale |
-2000.00 |
Cleaver Heath |
| 2024-08-01 |
Sale |
-2000.00 |
Aubert Paul |
| 2024-08-01 |
Sale |
-2000.00 |
Sherwood Aline |